BAKTERIENTHERAPIE FÜR CLOSTRIDIUM-DIFFICILE-COLITIS

Patent europeic · EP4032586 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4032586
Numer da la dumonda
EP22160187
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
01-02-2011
Publitgà
27-07-2022
Concedì
20-08-2025
La protecziun finescha il pli tard
31-01-2031
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
A61P 1/00 (2006.01)
C12N 1/04 (2006.01)
A61P 31/04 (2006.01)
A61P 1/12 (2006.01)
C12N 1/20 (2006.01)
Prioritad
US 33728310 P 01.02.2010
US 35118410 P 03.06.2010
Derivà da
EP19176151
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 28-05-2026

    Midada

    Published in Swissreg on 28.05.2026

  2. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  3. 20-08-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 20.08.2025

Partidas

Possessur

Ferring Microbiome Inc.

2660 Patton Road, Roseville, MN 55113, US

Inventur

HLAVKA, Edwin J

Minneapolis, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.